200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 813-93-4
813-93-4 | Bismuth(III) citrate
CAS No: 813-93-4 Catalog No: AG003OE8 MDL No:MFCD00050817
Product Description
Catalog Number:
AG003OE8
Chemical Name:
Bismuth(III) citrate
CAS Number:
813-93-4
Molecular Formula:
C6H5BiO7
Molecular Weight:
398.0801
MDL Number:
MFCD00050817
IUPAC Name:
bismuth;2-hydroxypropane-1,2,3-tricarboxylate
InChI:
InChI=1S/C6H8O7.Bi/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
InChI Key:
ANERHPOLUMFRDC-UHFFFAOYSA-K
SMILES:
[O-]C(=O)C(CC(=O)[O-])(CC(=O)[O-])O.[Bi+3]
EC Number:
212-390-1
UNII:
N04867Y76N
Properties
Complexity:
211
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
397.984g/mol
Formal Charge:
0
Heavy Atom Count:
14
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
398.079g/mol
Monoisotopic Mass:
397.984g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
141A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Efficacy of a modified sequential therapy including bismuth subcitrate as first-line therapy to eradicate Helicobacter pylori in a Turkish population. | Helicobacter 20121201 |
| Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori. | World journal of gastroenterology 20120828 |
| Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. | The British journal of nutrition 20120701 |
| Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients. | Singapore medical journal 20120401 |
| Bismuth ions inhibit the biological activity of non-amidated gastrins in vivo. | Biochemical pharmacology 20120215 |
| A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. | Helicobacter 20120201 |
| Is quadruple therapy the new triple therapy for H pylori? | Canadian family physician Medecin de famille canadien 20120101 |
| Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study. | Helicobacter 20110801 |
| Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies. | Medicine 20110501 |
| Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. | Alimentary pharmacology & therapeutics 20110401 |
| Studies of distribution and recurrence of Helicobacter spp. gastric mucosa of dogs after triple therapy. | Acta cirurgica brasileira 20110401 |
| Quadruple or triple therapy to eradicate H pylori. | Lancet (London, England) 20110312 |
| Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. | Lancet (London, England) 20110312 |
| [Rifaximin in combined treatment of the Helicobacter pylori infection in childhood]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101 |
| [Helicobacter pylori: what schemes of eradication are essential today?]. | Terapevticheskii arkhiv 20110101 |
| Considerable use of furazolidone in Iran. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20101001 |
| Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance. | Journal of digestive diseases 20101001 |
| Case of the month. MALT lymphoma. | JAAPA : official journal of the American Academy of Physician Assistants 20101001 |
| Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. | Journal of gastrointestinal cancer 20100901 |
| Helicobacter pylori infection. | The New England journal of medicine 20100805 |
| High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. | Helicobacter 20100601 |
| Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori. | Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100101 |
| Parallel on-line detection of a methylbismuth species by hyphenated GC/EI-MS/ICP-MS technique as evidence for bismuth methylation by human hepatic cells. | Metallomics : integrated biometal science 20100101 |
| Effect of bismuth citrate, lactose, and organic acid on necrotic enteritis in broilers. | Poultry science 20091101 |
| Peptic ulcer disease. | Lancet (London, England) 20091024 |
| A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine. | World journal of gastroenterology 20091007 |
| Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy. | Digestive diseases and sciences 20090901 |
| Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children. | Digestive diseases and sciences 20090801 |
| High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090801 |
| Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? | Helicobacter 20090801 |
| Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. | The Journal of antimicrobial chemotherapy 20090501 |
| Determination of trimethylbismuth in the human body after ingestion of colloidal bismuth subcitrate. | Drug metabolism and disposition: the biological fate of chemicals 20090201 |
| Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. | The American journal of gastroenterology 20090101 |
| Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial. | Wiener klinische Wochenschrift 20090101 |
| [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate]. | Terapevticheskii arkhiv 20090101 |
| [Rifaksimin in complex treatment of Helicobacter pylori infection in children (a pilot study)]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101 |
| Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. | Helicobacter 20081201 |
| Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease. | World journal of gastroenterology 20081028 |
| Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. | World journal of gastroenterology 20080628 |
| Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures. | European journal of clinical investigation 20080601 |
| [Efficacy of levofloxacin-based triple therapy as second-line Helicobacter pylori eradication]. | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080501 |
| Diclofenac-bismuth complex: synthesis, physicochemical, and biological evaluation. | Drug development and industrial pharmacy 20080401 |
| Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. | Alimentary pharmacology & therapeutics 20080215 |
| Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy. | Journal of gastroenterology and hepatology 20080101 |
| [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease]. | Klinicheskaia meditsina 20080101 |
| [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea]. | Klinicheskaia meditsina 20080101 |
| [Clinical response to de-nol in peptic ulcer patients]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101 |
| Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. | Helicobacter 20071201 |
| Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. | World journal of gastroenterology 20071028 |
| The protective roles of some lichen species on colloidal bismuth subcitrate genotoxicity. | Toxicology and industrial health 20070901 |
| A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori. | Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20070801 |
| Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. | Hepato-gastroenterology 20070601 |
| Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children. | Helicobacter 20070401 |
| [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer]. | Terapevticheskii arkhiv 20070101 |
| New drugs: retapamulin, bismuth subcitrate potassium, and rotigotine. | Journal of the American Pharmacists Association : JAPhA 20070101 |
| Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection. | BMC gastroenterology 20070101 |
| Randomized comparison of two rescue therapies for Helicobacter pylori infection. | European journal of clinical investigation 20061101 |
| [Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori]. | Annales de chirurgie 20061001 |
| Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility. | Journal of gastroenterology and hepatology 20061001 |
| Guidelines in the medical treatment of Helicobacter pylori infection. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20060901 |
| Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. | World journal of gastroenterology 20060814 |
| Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. | Pharmacy world & science : PWS 20060801 |
| Azithromycin in one week quadruple therapy for H pylori eradication in Iran. | World journal of gastroenterology 20060728 |
| Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. | World journal of gastroenterology 20060628 |
| Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate. | Chemical communications (Cambridge, England) 20060604 |
| Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients. | World journal of gastroenterology 20060521 |
| Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. | European journal of gastroenterology & hepatology 20060501 |
| Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea. | European journal of gastroenterology & hepatology 20060501 |
| Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. | World journal of gastroenterology 20060321 |
| Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. | Alimentary pharmacology & therapeutics 20060315 |
| Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20060201 |
| Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. | Helicobacter 20060201 |
| Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly. | Helicobacter 20060201 |
| Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone. | Alimentary pharmacology & therapeutics 20051101 |
| Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. | Journal of the National Cancer Institute 20050921 |
| Acute renal failure after overdose of colloidal bismuth subcitrate. | Pediatric nephrology (Berlin, Germany) 20050901 |
| Eradication rate of Helicobacter pylori in dyspeptic patients. | Medical science monitor : international medical journal of experimental and clinical research 20050401 |
| [The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate]. | Zhonghua nei ke za zhi 20050401 |
| Helicobacter pylori reinfection rate 3 years after successful eradication. | Journal of gastroenterology and hepatology 20050301 |
| Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis. | Helicobacter 20050201 |
| Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. | Alimentary pharmacology & therapeutics 20050115 |
| [Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?]. | Klinicheskaia meditsina 20050101 |
| [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial]. | Terapevticheskii arkhiv 20050101 |
| [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia]. | Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20050101 |
| Effects of bismuth citrate on the viability and function of Leydig cells and testicular macrophages. | Journal of applied toxicology : JAT 20050101 |
| [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20050101 |
| Biochemical response to colloidal bismuth subcitrate: dose-time effect. | Biological trace element research 20050101 |
| Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection. | Chinese journal of digestive diseases 20050101 |
| [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer]. | Klinicheskaia meditsina 20050101 |
| Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia. | Scandinavian journal of gastroenterology 20041201 |
| A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041101 |
| [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002]. | Orvosi hetilap 20041003 |
| The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20040901 |
| Total family unit Helicobacter pylori eradication and pediatric re-infection rates. | Helicobacter 20040801 |
| Inhibition of alcohol dehydrogenase by bismuth. | Journal of inorganic biochemistry 20040801 |
| Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline. | Journal of clinical pharmacology 20040601 |
| Helicobacter pylori: a historical perspective 1983-2003. | The New Zealand medical journal 20040521 |
| Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey. | World journal of gastroenterology 20040301 |
| Bismuth citrate in the quantification of inorganic phosphate and its utility in the determination of membrane-bound phosphatases. | Analytical biochemistry 20040101 |
| Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. | Alimentary pharmacology & therapeutics 20040101 |
| [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs]. | Terapevticheskii arkhiv 20040101 |
| Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)). | Journal of the American Chemical Society 20031015 |
| Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients. | Tropical doctor 20031001 |
| Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. | Archives of internal medicine 20030922 |
| The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials. | Gastroenterology 20030801 |
| Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. | Pharmacology & toxicology 20030801 |
| Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen. | Helicobacter 20030801 |
| A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. | Helicobacter 20030801 |
| [Failure of Helicobacter pylori eradication--suggestions for further therapy]. | Orvosi hetilap 20030629 |
| [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?]. | Gastroenterologia y hepatologia 20030501 |
| Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. | The American journal of gastroenterology 20030301 |
| [Bismuth subcitrate caused acute renal failure in a child]. | Zhonghua er ke za zhi = Chinese journal of pediatrics 20030201 |
| [The state of immune system and effects of current therapy and immunomodulators]. | Klinicheskaia meditsina 20030101 |
| [Effectiveness of using immunomodulators in combined treatment of patients with chronic gastritis and ulcer disease]. | Klinicheskaia meditsina 20030101 |
| [Microcirculatory disorders in chronic erosions of the stomach]. | Klinicheskaia meditsina 20030101 |
| In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101 |
| [Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs]. | Klinicheskaia meditsina 20030101 |
| A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. | Gastroenterology 20021201 |
| Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. | European journal of gastroenterology & hepatology 20021101 |
| Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study. | Helicobacter 20021001 |
| Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection. | Alimentary pharmacology & therapeutics 20020801 |
| One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial. | Alimentary pharmacology & therapeutics 20020701 |
| Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole. | Alimentary pharmacology & therapeutics 20020701 |
| Bismuth-induced lysosomal rupture in J774 cells. | APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20020501 |
| Pathways of proximal tubular cell death in bismuth nephrotoxicity. | Toxicology and applied pharmacology 20020415 |
| Bismuth subcitrate nephrotoxicity. A reversible cause of acute oliguric renal failure. | Nephron 20020401 |
| Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. | The American journal of gastroenterology 20020401 |
| Fanconi's syndrome, acute renal failure, and tonsil ulcerations after colloidal bismuth subcitrate intoxication. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20020301 |
| [Helicobacter heilmannii-associated gastritis]. | Nihon rinsho. Japanese journal of clinical medicine 20020201 |
| One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. | Journal of clinical gastroenterology 20020101 |
| [Changes in local humoral immunity during stomach ulcer healing with laser and drug therapy]. | Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101 |
| Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide. | Drugs in R&D 20020101 |
| Human biokinetics of injected bismuth-207. | Human & experimental toxicology 20011201 |
| Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011115 |
| Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. | Gastroenterology 20011001 |
| Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease. | European journal of gastroenterology & hepatology 20011001 |
| Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010901 |
| Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. | European journal of gastroenterology & hepatology 20010801 |
| Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment. | Alimentary pharmacology & therapeutics 20010701 |
| Helicobacter pylori and iron deficiency anaemia in children. | Scandinavian journal of gastroenterology 20010701 |
| Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. | Alimentary pharmacology & therapeutics 20010601 |
| Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate. | Pediatric nephrology (Berlin, Germany) 20010601 |
| Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe? | Helicobacter 20010601 |
| Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection. | European journal of gastroenterology & hepatology 20010501 |
| Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. | The New England journal of medicine 20010329 |
| Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. | Annals of internal medicine 20010306 |
| Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. | Alimentary pharmacology & therapeutics 20010301 |
| The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. | The Israel Medical Association journal : IMAJ 20010301 |
| Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate. | Scandinavian journal of gastroenterology 20010201 |
| Bismuth overdosing-induced reversible nephropathy in rats. | Archives of toxicology 20010201 |
| Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. | The American journal of gastroenterology 20010101 |
| Survey of dyspepsia management in community. | Singapore medical journal 20010101 |
| [Current principles of the use of laparoscopic surgery in gastroduodenal ulcer]. | Khirurgiia 20010101 |
| [How to overcome antibiotic resistance of Helicobacter pylori. Role of de-nol in current schemes of eradication therapy]. | Terapevticheskii arkhiv 20010101 |
| Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20010101 |
| Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen. | Digestion 20010101 |
| Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. | Helicobacter 20000901 |
| The mode of action of colloidal bismuth subcitrate. | Scandinavian journal of gastroenterology. Supplement 19910101 |
| Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. | Drugs 19880801 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.